As companies move their cell and gene therapies through the development process, supporting larger Phase III trials and commercial launches will be a challenge
Ryan Carpentier, Executive Director of Business Development, Cryoport09.23.19
Dr. Allan Jordan and Ms. Louisa Jordison have joined the company as director of Oncology Drug Discovery and director of Strategic Planning, respectively